Verity & Verity’s Thermo Fisher Scientific TMO Stock Holding History

Verity & Verity’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,190	Closed	-$658K	–	123
2024 Q2	$658K	Sell	1,190 -34	-3%	-$19.5K	0.07%	74
2024 Q1	$711K	Buy	1,224 +5	+0.4%	+$2.81K	0.08%	75
2023 Q4	$647K	Sell	1,219 -5	-0.4%	-$2.42K	0.07%	74
2023 Q3	$620K	Hold	1,224	–	–	0.08%	72
2023 Q2	$639K	Sell	1,224 -400	-25%	-$216K	0.08%	71
2023 Q1	$936K	Sell	1,624 -10	-0.6%	-$5.64K	0.12%	72
2022 Q4	$900K	Buy	1,634 +359	+28%	+$190K	0.12%	81
2022 Q3	$647K	Buy	1,275 +41	+3%	+$22.9K	0.1%	74
2022 Q2	$670K	Buy	1,234 +34	+3%	+$18.7K	0.1%	75
2022 Q1	$709K	Hold	1,200	–	–	0.1%	73
2021 Q4	$801K	Hold	1,200	–	–	0.11%	70
2021 Q3	$771K	Hold	1,200	–	–	0.12%	70
2021 Q2	$605K	Hold	1,200	–	–	0.1%	72
2021 Q1	$579K	Hold	1,200	–	–	0.09%	72
2020 Q4	$616K	Buy	+1,200	New	+$563K	0.12%	71
2017 Q4	–	Sell	-1,111	Closed	-$210K	–	97
2017 Q3	$210K	Buy	+1,111	New	+$201K	0.06%	91

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verity & Verity's TMO Position: Q3 2024 in Review

Verity & Verity sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 1,190 shares — an estimated $658K sold.

Verity & Verity first reported a position in TMO in Q3 2017 and held it in 16 quarters. The position peaked at $936K in Q1 2023. 2,574 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Verity & Verity reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
Verity & Verity sold 1,190 Thermo Fisher Scientific shares in Q3 2024, an estimated $658K.
Verity & Verity first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 16 quarters.
Verity & Verity's Thermo Fisher Scientific position peaked at $936K in Q1 2023.
2,574 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Verity & Verity's 13F filing for Q3 2024, filed 7 Nov 2024.